The public offering of B&K CORP-B received 791.95 times subscription, with a 2.5% chance of winning one lot

B&K CORP-B (02396.HK) announced the results of its IPO, with the Hong Kong public offering receiving 791.95 times subscription, and the winning rate for one board lot (200 shares) at 2.5%, with a subscription of 250,000 shares securing one board lot. The international offering recorded 6.05 times subscription. The final offer price is HKD 38.2, at the lower end of the price range, raising a net amount of HKD 600 million. The shares are expected to be listed on Monday (22nd).

Focusing on wound healing therapies, the biopharmaceutical company B&K CORP-B plans to issue a total of 17,648,800 shares globally, with 10% allocated for the public offering. The offer price ranges from HKD 38.2 to HKD 51. The joint sponsors are Huatai International and CITIC Securities